drugset / Trial / NCT03316963
Neostigmine For Snoring During DISE
NaSingle-groupOpen-labelTreatment
Summary
The study team is seeking a novel treatment for snoring involving local application of a nerve stimulant medication, neostigmine. In this study, neostigmine will be injected into 5 sites of the soft palate during a standard procedure, drug-induced sleep endoscopy, to evaluate the effect on snoring.
Timeline
- Start
- 2017-11-14
- Primary completion
- 2019-03-19
- Completion
- 2019-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neostigmine | Other / unclassified | 2.5 mg | Other |
Indications
No indication recorded.